Carl Zeiss Meditec AG

OTC: CZMWY · Real-Time Price · USD
68.31
1.28 (1.91%)
At close: Jun 06, 2025, 3:58 PM

Carl Zeiss Meditec Income Statement

Financials in EUR. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Revenue
2.07B 2.09B 1.9B 1.65B
Cost of Revenue
977.5M 883.53M 775.24M 679.57M
Gross Profit
1.09B 1.21B 1.13B 967.21M
Operating Income
194.45M 327.14M 413.08M 348.42M
Interest Income
23.27M 29.05M 13.25M 1.56M
Pretax Income
240.87M 412.56M 403.49M 339.05M
Net Income
178.73M 290.4M 293.91M 236.28M
Selling & General & Admin
569.21M 504.06M 438.06M 363.98M
Research & Development
343.09M 375.81M 291.37M 232.07M
Other Expenses
-18.12M n/a 1.29M -2.45M
Operating Expenses
894.18M 878.63M 730.72M 593.6M
Interest Expense
29.42M 1.92M 9.59M 9.37M
Selling & Marketing Expenses
458.2M 420.28M 360.18M 303.23M
Cost & Expenses
1.87B 1.76B 1.51B 1.27B
Income Tax Expense
60.71M 120.56M 107.58M 101.53M
Shares Outstanding (Basic)
88.85M 89.44M 89.44M 89.44M
Shares Outstanding (Diluted)
88.85M 89.44M 89.44M 89.44M
EPS (Basic)
2.01 3.25 3.29 2.64
EPS (Diluted)
2.01 3.25 3.29 2.64
EBITDA
403.06M 501.88M 482.85M 410M
EBIT
270.29M 427.81M 413.08M 348.42M
Depreciation & Amortization
132.77M 74.06M 69.77M 61.58M